TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Effectiveness of combined therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rhinitis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: native liver survival
Endpoint domain: Mortality/survival
Primary endpoint: Awareness rate of lung expansion therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Correct rate of education of lung expansion therapy
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Average trajectory of irinotecan, raloxifene, XCHT and their metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: students' self-confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: satisfaction with education methods
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Natural Birth Approach Skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute effect on brain electrical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Identification of new pathophysiological mechanisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in neutralizing antibody levels against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Tantrum Questionnaire Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Satisfaction and well-being visual analog scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Discovery of VOC Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Women's experiences of postnatal perineal wound assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical discomfort during postnatal perineal wound assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Shorts Physical Performance Battery (SPPB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ISPCAN Child Abuse Screening Tool-Intervention (ICAST-TP) - Physical and Emotional Abuse Subscales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of overall abuse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with tight controlled diabetes melitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lung cancer surgery outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain after gingival graft harvesting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants receiving 2 doses of dexamethasone
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Ventilator weaning outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Rate of disease resolution of peri-implantitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of missed period pill regimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Vastus lateralis cross-sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with ≥2 points improvement on the INCAT disability score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of adverse events during treatment and follow up by the Common Terminology Criteria for Adverse Events (CTCAE), version 5
Endpoint domain: Adverse events/effects
Primary endpoint: Study Drug adherence
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Normalization of oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Coagulation system activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Use of hypnotics assessed as days per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insomnia severity assessed with Insomnia Severity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insomnia severity assessed with Bergen Insomnia Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global complications rate
Endpoint domain: Adverse events/effects
Primary endpoint: Change in RBC/Membrane Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Global Physical Literacy Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Relative Index Change During PACU Stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Change of the language impairment rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of skeletal muscle area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of handgrip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of relative skeletal muscle mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Readmission due to infection
Endpoint domain: Adverse events/effects
Primary endpoint: Total use of antibiotics
Endpoint domain: Resource use
Primary endpoint: Incidence of systemic toxicity from local anesthetic signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Numeric Pain Scale assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: occurrence of hypotension
Endpoint domain: Adverse events/effects
Primary endpoint: Recruitment interest
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Denture retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with esthetics
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction with comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Occurrence of complete abortion within 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Non-invasive tear meniscus height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First tear film break-up time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dry eye severity grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Microvascular flow index (MFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG alpha-band power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postural sway speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite endpoint for technique failure and death
Endpoint domain: Mortality/survival
Primary endpoint: Changes in facial acne
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in blood serum levels of vitamin A
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in participants perception of facial acne
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Range of motion (ROM) of upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain of upper extremity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type of spontaneous breathing trial performed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: IL-38 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety related to lead extraction procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients achieving ACR 50 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Characterize the pharmacodynamics (PD) of TRL1068 (time to resolution of bacterial pathogen infection)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Characterize the pharmacodynamics (PD) of TRL1068 (time to resolution of signs and symptoms of acute exacerbation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in anti-EPX IgG in airway secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Parents' anxiety state
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain experienced by gastrointestinal system cancer patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Fatigue experienced by patients with gastrointestinal system cancer
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Insomnia experienced by patients with gastrointestinal system cancer
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Nausea and vomiting experienced by patients with gastrointestinal system cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of Participants With Solicited Local Reactions and Systemic AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants With Unsolicited AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants With RSV/A, RSV/B, hMPV/A and hMPV/B Neutralizing Antibodies (NAb)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of Participants With RSV and hMPV Immunoglobulin G (IgG) Prefusion F Protein-specific Antibody Titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of change in Anesthetic Plan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of pregnancies in Turner syndrome women
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of miscarriages in pregnant Turner syndrome women
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Number of liveborn children birthed by Turner syndrome women
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: perfusion density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perimeter and area of the fovea avascular zone (FAZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survivor participant feedback on breast cancer care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinician participant reports on experiences in caring for LGBTQ+ people
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: change of maximal oxygen consumption (VO2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of Chronic obstructive pulmonary disease (COPD) assessment Test (CAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: change of Korean Health-related Quality of Life Instrument with 8 Items (HINT-8) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Accurate dressing change rate of pressure injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Time Up and Go Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Depression, Anxiety and Stress Scale (DASS-21)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of participants with immunity to COVID-19 vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: The Bournemouth Questionnaire for Neck Pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Fremantle Neck Awareness Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Known Groups Validity of VR TASIT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of VR TASIT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attendance at prenatal care visits through pregnancy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total Number of Participants Who Were Eligible and Enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percent of FB Sessions Attended
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Satisfied With Friendship Bench
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Counseling Sessions Meeting Fidelity Threshold
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Freedom from documented atrial arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Area Under the Concentration-time Curve of BI 765080 in Plasma (AUC0-tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Measured Concentration of BI 765080 in Plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of early renal manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Associative Memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: major adverse event (MAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Caregiving related stress
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Negative remodeling prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of serum ATX
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Efficacy in treating fungal foot infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Urinary stone risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Calcium Oxalate Inhibitor activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Patients Achieving Corneal Healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of major wound complications
Endpoint domain: Adverse events/effects
Primary endpoint: Grams of hospital meals consumed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Calories of hospital meals consumed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Speech/Articulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tongue mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Asthma Control Test
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Movement Disorder Society-Sponsored Unified Parkinson's Disease Rating Scale - Part III (MDS UPDRS-III)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change in taste threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mood (assessed by score on the Beck Depression Inventory)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Neurovascular coupling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change of LUS-evaluated pulmonary congestion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of IAP0971
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness of IAP0971
Endpoint domain: Physiological/clinical
Primary endpoint: Proportion of neonates/mothers visited at home by village health volunteers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of neonates/mothers receiving information regarding danger signs of newborn illnesses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Liver fat content decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Efficacy of Fractional RF for Acne Vulgaris
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of RRT-free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Back belief assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postprandial Plasma Essential Amino Acid Concentration Incremental Area-under-the-curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Right ventricular remodeling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients receiving relative dose intensity (RDI) <85%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful rate of gastric placement of feeding tubes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Active matrix metalloproteinase 8 (aMMP-8)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Operative Hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitality-Success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Multiorgan failure improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in DD Clinical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eosinophil Histologic Response (≤ 6/hpf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in regional lung perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of postoperative major adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Ascent Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in concentration of PFAS levels in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in epigenetic age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive IgE levels for beef
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants with Injection Site Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: completion of complete ablation without technical failures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: procedure-related adverse events and complications following SIR criteria
Endpoint domain: Adverse events/effects
Primary endpoint: Patients' and families' feeling of being informed
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patients' and families' feeling of security about future care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of patients with a therapeutic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distribution of scores on the modified Rankin scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Recurrent stroke events
Endpoint domain: Mortality/survival
Primary endpoint: Hospitalization due to influenza or pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Perceived acceptability of eCDSS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effective rate of bleeding treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in lesion fluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Vaccination Rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Follow-Up Visit Addressing Gout
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Level of platelet aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Within-person change in score on the Ruminative Responses Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Hamilton Depression Scale (HDS-6)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Completeness of coverage of tumor vasculature by therapeutic agent
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Adherence to OSA treatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Sum of located margin resection widths
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pathologic outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rehabilitation progress
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sedation range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes